A Pragmatic Cluster Randomized Controlled Trial to Standardize Attending

Status Completed

Clinical Trial Summary

Attending morning rounds take place at teaching hospitals every day. They are the primary mechanism for patient care delivery, supervision and education of trainees, and communication with patients, families, and staff. However, they are done with little standardization or widely recognized best practices.

The objective of this quality improvement (QI) initiative is to evaluate the adherence to and impact of implementing standardized attending morning rounds on medicine teams at our institution. A standardized rounding intervention has been developed which includes specific guidance on completing the following activities during morning rounds: (1) Pre-rounds discretion; (2) Pre-rounds huddle; (3) Bedside registered nurse (RN) integration; (4) Patient-centered rounding; (5) Real-time order writing.

This trial will randomize half of the investigators' medicine teams at University of California San Francisco to this rounding intervention whilst the other half will be randomized to continue with usual unstandardized rounding practices.

The investigators will compare medicine teams randomized to undertake standardized rounding to those teams undertaking usual practice. Outcomes assessed will relate to the patient (e.g. satisfaction), providers (e.g. satisfaction), efficiency (e.g. total morning round time) as well as adherence to the intervention .

The investigators' study hypotheses are that patient satisfaction scores will be higher for those patients receiving standardized bedside rounds compared to the usual care group. The investigators also hypothesize that total attending morning rounds time and interns length of workday will be shorter and that the number of consultations ordered before noon will increase for those teams undertaking standardized bedside. Further, the investigator hypothesize higher levels of nurse participation, physician and medical student satisfaction with standardized bedside rounding.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Single Blind (Subject), Primary Purpose: Health Services Research

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01931553
Study type	Interventional
Source	University of California, San Francisco
Contact
Status	Completed
Phase	N/A
Start date	September 2013
Completion date	December 2014

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03297567` - Physical Therapy Guidelines For Hospitalized Elderly	N/A
Terminated	`NCT03825497` - The WALK-Copenhagen Trial (WALK-Cph): a Mixed Methods Study	N/A
Completed	`NCT06293768` - Continuous Wireless Monitoring for Patients in the Internal Medicine UOC. Randomized Controlled Trial (GreenLineH-T)	N/A
Completed	`NCT03296423` - Bacillus Calmette-guérin Vaccination to Prevent Infections of the Elderly	Phase 4
Not yet recruiting	`NCT05550272` - Hospitalizations in Neonatal Period and Early Discharge of Maternity
Completed	`NCT02614638` - Evaluation of the Impact of the Presence of a Pharmacy Technician on the Quality and Cost of Drug Therapy	N/A
Completed	`NCT00527774` - Effect of HCV Infection on Insulin Resistance and Malnutrition-inflammation Complex Syndrome in Regular Hemodialysis Patients	N/A
Completed	`NCT02598115` - Impact of Collaborative Pharmaceutical Care on Hospital Admission Drug Prescriptions for Patients 65 Years of Age and Older	N/A
Recruiting	`NCT05366075` - The Preventing Functional Decline in Acutely Hospitalized Older Patients (PREV_FUNC) Study	Phase 3
Not yet recruiting	`NCT05522647` - Detection of Risk Behaviors: Pilot Observational Study With Bedridden and Agitated Patients.
Terminated	`NCT04257422` - Intentional Rounding in Internal Medicine	N/A
Completed	`NCT00370916` - Reducing Transition Drug Risk	N/A
Completed	`NCT00244673` - Randomized Study of Not Giving Diphteria-tetanus-pertussis Vaccination With or After Measles Vaccination	Phase 4
Recruiting	`NCT04078334` - Personalized Exercises Program Prescription to Prevent Functional Decline Throughout Older Adults Hospitalization	N/A
Active, not recruiting	`NCT04235374` - Implementation of Function Focused Care in Acute Care	N/A
Recruiting	`NCT03651414` - Safety Issues and SurvIval For Medical Outliers
Completed	`NCT05247060` - Orthostatic Hypotension in Hypertensive Patient Hospitalized in Internal Medicine
Terminated	`NCT05518474` - Self-proning and Repositioning in COVID-19 Outpatients at Risk of Complicated Illness	N/A
Recruiting	`NCT04033718` - Inpatient Package to Reduce HIV and AIDS-related Death in Zambia	N/A
Recruiting	`NCT05036824` - Intensive Dose Tinzaparin in Hospitalized COVID-19 Patients

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

A Pragmatic Cluster Randomized Controlled Trial to Standardize Attending Morning Rounds in Medicine

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms